http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bfe8291761c81e2f00f9088d3cf2ee5e
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Neste Van Neste |
| name | Leander Van Neste |
| given-name | Leander Leander Van |
| organization-name | 1Department of Pathology, GROW - School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, the Netherlands. Authors' Affiliations: Departments of 1Pathology, 2Radiation Oncology (MAASTRO) and 3Epidemiology, GROW-School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, the Netherlands; 4Service de Pathologie; 5Registre des cancers digestifs, Université de Bourgogne, Centre Hospitalier Universitaire de Dijon, Dijon, France; and 6The Sidney Kimmel Comprehensive Cancer Center at the Johns Hopkins University School of Medicine, Baltimore, Maryland 4Department of Molecular Biotechnology, Faculty of Bioscience Engineering, Ghent University, Ghent, Belgium Department of Pathology Maastricht University Medical Center Maastricht The Netherlands 2Department of Pathology, School for Oncology and Developmental Biology (GROW), Maastricht University Medical Centre, Maastricht, the Netherlands. Authors' Affiliations: Departments of 1Oncology, 2Surgery, 3Urology, and 4Mechanic Engineering, Johns Hopkins University; 5Department of Biomedical Engineering, Johns Hopkins School of Medicine; 6Department of Pathology, The Sol Goldman Pancreatic Research Center, The Johns Hopkins Medical Institutions, Baltimore, Maryland; 7MDxHealth, Ghent, Belgium; and 8Research Institute, Dongnam Institute of Radiological and Medical Sciences (DIRAMS), Busan, South Korea Director of Scientific Affairs and Research at MDxHealth Inc, Irvine, CA, and Assistant Professor at the University of Maastricht, The Netherlands. Authors' Affiliations: Departments of 1Oncology, 2Surgery and 3Pathology, Johns Hopkins University, Baltimore, Maryland; 4Faculty of Bioscience Engineering, Department of Molecular Biotechnology, Ghent University, Ghent, Belgium; 5MDxHealth, Ghent, Belgium 6Cancer Research UK Viral Oncology Group, University College London, London, United Kingdom; 7Department of Pathology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, the Netherlands; 8Laboratory of Neurogenetics, NIAAA, NIH, Bethesda, Maryland; 9Research Center, Dongnam Institute of Radiological & Research Medical Sciences (DIRAMS), Busan, South Korea; Authors' Affiliations: Departments of 1Oncology, 2Surgery and 3Pathology, Johns Hopkins University, Baltimore, Maryland; 4Faculty of Bioscience Engineering, Department of Molecular Biotechnology, Ghent University, Ghent, Belgium; 5MDxHealth, Ghent, Belgium 6Cancer Research UK Viral Oncology Group, University College London, London, United Kingdom; 7Department of Pathology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, the Netherlands; 8Laboratory of Neurogenetics, NIAAA, NIH, Bethesda, Maryland; 9Research Center, Dongnam Institute of Radiological & Research Medical Sciences (DIRAMS), Busan, South Korea 3Department of Molecular Biotechnology, Faculty of Bioscience Engineering, Ghent University, Ghent, Belgium; and 4Department of Molecular Biotechnology, Faculty of Bioscience Engineering, Ghent University, Ghent, Belgium; Authors' Affiliations: Departments of 1Molecular Cell Biology, 2Pathology, and 3Pulmonology, GROW—School for Oncology & Developmental Biology, Maastricht University Medical Center, Maastricht; 4Department of Pathology, Jeroen Bosch Hospital, 's-Hertogenbosch; 5Department of Pathology, Erasmus MC—University Medical Center, Rotterdam; 6Department of Pathology, VU University Medical Center, Amsterdam, the Netherlands; 7MDxHealth, Irvine, California; 8Institute for Pathology, Technical University Munich, Munich, Germany; 9Department of Clinical and Biological Sciences, Division of Pathology, University of Turin at San Luigi Hospital, Orbassano, Turin, Italy; and 10Laboratory of Bioinformatics and Computational Genomics, Ghent University, Ghent, Belgium Department of Pathology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands; MDxHealth, Inc., Irvine, California Authors' Affiliations: 1The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland; 2Department of Molecular Biotechnology, Faculty of Bioscience Engineering, Ghent University, Ghent, Belgium; 3Biometry and Clinical Trials, The Johns Hopkins Kimmel Cancer Center, Baltimore, Maryland; 4University of Massachusetts Medical School, North Worcester, Massachusetts; and 5Laboratory of Neurogenetics, National Institute on Alcohol Abuse and Alcoholism, Rockville, Maryland 2Department of Molecular Biotechnology, Faculty of Bioscience Engineering, Ghent University, Ghent, Belgium Department of Molecular Biotechnology, Faculty of Bioscience and Engineering, Ghent University, Ghent B-9000, Belgium. Authors' Affiliations: 1The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland; 2Department of Molecular Biotechnology, Faculty of Bioscience Engineering, Ghent University, Ghent, Belgium; 3MDxHealth Inc, Irvine, California; 4Shinshu University School of Medicine, Asahi, Matsumoto, Nagano, Japan; and 5Lovelace Respiratory Research Institute, Albuquerque, New Mexico; Authors' Affiliations: 1The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland; 2Department of Molecular Biotechnology, Faculty of Bioscience Engineering, Ghent University, Ghent, Belgium; 3MDxHealth Inc, Irvine, California; 4Shinshu University School of Medicine, Asahi, Matsumoto, Nagano, Japan; and 5Lovelace Respiratory Research Institute, Albuquerque, New Mexico Department of Pathology, GROW School for Oncology and Developmental Biology Maastricht University Medical Center Maastricht The Netherlands 1Department of Pathology, GROW-School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, the Netherlands.; 4MDxHealth, Herstal, Belgium. 4Department of Molecular Biotechnology, Faculty of Biosciences Engineering, Ghent University, Ghent, Belgium Department of Pathology, GROW-School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands; MDxHealth, Inc., Irvine, California Authors' Affiliations: 1Sidney Kimmel Comprehensive Cancer Center, 2Program in Cellular and Molecular Medicine, 3Institute for Cell Engineering and Department of Medicine, 4Bioinformatics, 5Department of Biomedical Engineering, and 6Department of Pediatric Oncology, Johns Hopkins University School of Medicine; 7Department of Pathology and 8Molecular and Comparative Pathobiology, Johns Hopkins Medical Institutions; 9Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, Maryland; 10Department of Molecular Biotechnology, Faculty of Bioscience Engineering, Ghent University, Ghent, Belgium; and 11OncoMethylome Sciences, SA, Liege, Belgium; Authors' Affiliations: 1Sidney Kimmel Comprehensive Cancer Center, 2Program in Cellular and Molecular Medicine, 3Institute for Cell Engineering and Department of Medicine, 4Bioinformatics, 5Department of Biomedical Engineering, and 6Department of Pediatric Oncology, Johns Hopkins University School of Medicine; 7Department of Pathology and 8Molecular and Comparative Pathobiology, Johns Hopkins Medical Institutions; 9Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, Maryland; 10Department of Molecular Biotechnology, Faculty of Bioscience Engineering, Ghent University, Ghent, Belgium; and 11OncoMethylome Sciences, SA, Liege, Belgium Department of Pathology, GROW School for Oncology and Developmental BiologyMaastricht University Medical CenterMaastrichtThe Netherlands MDxHealth, Inc., Irvine, California MDxHealth PharmacoDx, Technologiepark 4, 9052 Ghent, Belgium Authors' Affiliations: Departments of 1Surgery, 2Oncology, and 3Pathology, Johns Hopkins University, Baltimore, Maryland; 4Institute of Human Genetics, University Hospital Erlangen, University of Erlangen-Nürnberg, Erlangen, Germany; 5MDxHeatlth SA, Liège, Belgium; and 6Department of Pathology, GROW-School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, the Netherlands Immunis.AI, Royal Oak, Michigan |
Incoming Links
Total number of triples: 82.